Related references
Note: Only part of the references are listed.The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Impact of antipsychotic medication on IL-6/STAT3 signaling axis in peripheral blood mononuclear cells of drug-naive schizophrenia patients
Manjula Subbanna et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2020)
Effects of Antipsychotic Drugs: Cross Talk Between the Nervous and Innate Immune System
Ayushi Anna Dinesh et al.
CNS DRUGS (2020)
Systemic Inflammation in Metabolic Syndrome: Increased Platelet and Leukocyte Activation, and Key Role of CX3CL1/CX3CR1 and CCL2/CCR2 Axes in Arterial Platelet-Proinflammatory Monocyte Adhesion
Patrice Marques et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Alteration of Serum Levels of Cytokines in Schizophrenic Patients before and after Treatment with Risperidone
Esfandiar Azizi et al.
Iranian Journal of Allergy Asthma and Immunology (2019)
Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis
David R. Goldsmith et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first episode psychosis
Mariane Nunes Noto et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2019)
Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study
Emanuela Martinuzzi et al.
TRANSLATIONAL PSYCHIATRY (2019)
Kinetics of Cytokine Levels during Antipsychotic Treatment in Schizophrenia: A Meta-Analysis
Bruno Romeo et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
Comparison of the anti-inflammatory effect of aripiprazole and risperidone in 75 drug-naive first episode psychosis individuals: A3 months randomized study
Maria Juncal-Ruiz et al.
SCHIZOPHRENIA RESEARCH (2018)
Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions
Brian J. Miller et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Oxidative Stress and Inflammation in Early Onset First Episode Psychosis: A Systematic Review and Meta-Analysis
David Fraguas et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2017)
The kynurenine pathway and the brain: Challenges, controversies and promises
Robert Schwarcz et al.
NEUROPHARMACOLOGY (2017)
Acute variations of cytokine levels after antipsychotic treatment in drug-naive subjects with a first-episode psychosis: A meta-analysis
Enrico Capuzzi et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)
Changes in the cytokine profile in first-episode, drug-naive patients with psychosis after short-term antipsychotic treatment
Petros Petrikis et al.
PSYCHIATRY RESEARCH (2017)
Antipsychotic-induced weight gain in first-episode psychosis patients: a meta-analysis of differential effects of antipsychotic medications
Cenk Tek et al.
EARLY INTERVENTION IN PSYCHIATRY (2016)
Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population
Krithika Srikanthan et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2016)
Serum IL-4 and IL-10 Levels Correlate with the Symptoms of the Drug-Naive Adolescents with First Episode, Early Onset Schizophrenia
Seref Simsek et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2016)
An Open-Label, Pilot Trial of Adjunctive Tocilizumab in Schizophrenia
Brian J. Miller et al.
JOURNAL OF CLINICAL PSYCHIATRY (2016)
A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression
D. R. Goldsmith et al.
MOLECULAR PSYCHIATRY (2016)
Evidence for increased immune mobilization in First Episode Psychosis compared with the prodromal stage in males
Evangelos Karanikas et al.
PSYCHIATRY RESEARCH (2016)
Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset
Ewa Bulzacka et al.
SCHIZOPHRENIA BULLETIN (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [11C]DPA-713 PET and analysis of CSF and plasma
J. M. Coughlin et al.
TRANSLATIONAL PSYCHIATRY (2016)
Inflammation and metabolic changes in first episode psychosis: Preliminary results from a longitudinal study
Alice Russell et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis
Valeria Mondelli et al.
SCHIZOPHRENIA BULLETIN (2015)
Antipsychotic treatment reduces psychotic symptoms and markers of low-grade inflammation in first episode psychosis patients, but increases their body mass index
Liina Haring et al.
SCHIZOPHRENIA RESEARCH (2015)
Effects of Risperidone on Cytokine Profile in Drug-Naive First-Episode Psychosis
Cristiano Noto et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
Adjunctive Recombinant Human Interferon Gamma-1b for Treatment-Resistant Schizophrenia in 2 Patients
Lena Grueber et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
Inflammation and the two-hit hypothesis of schizophrenia
Keith A. Feigenson et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2014)
Activation of Th17 cells in drug naive, first episode schizophrenia
Minli Ding et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)
Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug na < ve, first-episode schizophrenia
Xueqin Song et al.
PSYCHOPHARMACOLOGY (2014)
Pro-/Anti-inflammatory Dysregulation in Patients With First Episode of Psychosis: Toward an Integrative Inflammatory Hypothesis of Schizophrenia
Borja Garcia-Bueno et al.
SCHIZOPHRENIA BULLETIN (2014)
Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment
Lot de Witte et al.
SCHIZOPHRENIA RESEARCH (2014)
Risperidone normalizes increased inflammatory parameters and restores anti-inflammatory pathways in a model of neuroinflammation
Karina S. MacDowell et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Chronic Interferon-α Decreases Dopamine 2 Receptor Binding and Striatal Dopamine Release in Association with Anhedonia-Like Behavior in Nonhuman Primates
Jennifer C. Felger et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Adjunctive Use of Nonsteroidal Anti-inflammatory Drugs for Schizophrenia: A Meta-analytic Investigation of Randomized Controlled Trials
Masahiro Nitta et al.
SCHIZOPHRENIA BULLETIN (2013)
Antipsychotics' effects on blood levels of cytokines in schizophrenia: A meta-analysis
Valerie Tourjman et al.
SCHIZOPHRENIA RESEARCH (2013)
Antipsychotics can modulate the cytokine profile in schizophrenia: Attenuation of the type-2 inflammatory response
Milica Borovcanin et al.
SCHIZOPHRENIA RESEARCH (2013)
Altered immune function in unaffected first-degree biological relatives of schizophrenia patients
Isabel Martinez-Gras et al.
PSYCHIATRY RESEARCH (2012)
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
Brian J. Miller et al.
BIOLOGICAL PSYCHIATRY (2011)
Anti-Inflammatory Properties of Antipsychotics Via Microglia Modulations: Are Antipsychotics a ‘Fire Extinguisher’ in the Brain of Schizophrenia?
T. A. Kato et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2011)
The Interaction of Nuclear Factor-Kappa B and Cytokines Is Associated with Schizophrenia
Xue-Qin Song et al.
BIOLOGICAL PSYCHIATRY (2009)
Review of the operational definition for first-episode psychosis
Nicholas J. K. Breitborde et al.
EARLY INTERVENTION IN PSYCHIATRY (2009)
Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring
Stephen L. Buka et al.
BIOLOGICAL PSYCHIATRY (2008)
Inhibitory effects of aripiprazole on interferon-γ-induced microglial activation via intracellular Ca2+ regulation in vitro
Takahiro Kato et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Lower serum cytokine levels in smokers than nonsmokers with chronic schizophrenia on long-term treatment with antipsychotics
Xiang Yang Zhang et al.
PSYCHOPHARMACOLOGY (2008)
Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia nigra
Toyoko Arimoto et al.
NEUROBIOLOGY OF AGING (2007)
Risperidone significantly inhibits interferon-γ-induced microglial activation in vitro
Takahiro Kato et al.
SCHIZOPHRENIA RESEARCH (2007)
Dopamine and noradrenaline control distinct functions in rodent microglial cells
K Färber et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2005)
Serologic-evidence of prenatal influenza in the etiology of schizophrenia
AS Brown et al.
ARCHIVES OF GENERAL PSYCHIATRY (2004)
T cell deficiency leads to cognitive dysfunction: Implications for therapeutic vaccination for schizophrenia and other psychiatric conditions
J Kipnis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Maternal infections and subsequent psychosis among offspring
SL Buka et al.
ARCHIVES OF GENERAL PSYCHIATRY (2001)
Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients
S Theodoropoulou et al.
SCHIZOPHRENIA RESEARCH (2001)
Share Paper
